More patients receiving semaglutide discontinued because of GI symptoms, including nausea, diarrhoea and vomiting.
The Australian Therapeutic Goods Administration (TGA) classifies semaglutide as a Category D medication for pregnancy, meaning theres evidence of human fetal risk but the benefits may still outweigh risks in certain situations (like poorly controlled diabetes)
These non-medication strategies carry no risk to milk supply or infant health and provide a bridge until medication options become appropriate post-weaning
And in the comparison between phentermine and GLP-1 medications, the numbers tell a story that is difficult to argue with
That is the only thing you need to remember
Authorship Information: Concept and design (MU, CNT, LG, TMK)